Antioxidant to treat osteoarthritis: Dream or reality?

被引:99
作者
Henrotin, Y.
Kurz, B.
机构
[1] Univ Liege, Bone & Cartilage Res Unit, Inst Pathol, CHU Sart Tilman, B-4000 Liege, Belgium
[2] Univ Kiel, Inst Anat, D-24098 Kiel, Germany
关键词
osteoarthritis; cartilage; oxygen; free radicals; antioxidants;
D O I
10.2174/138945007779940151
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Osteoarthritis is one of the most common chronic diseases that causes pain and physical disability in patient. Although OA is considered as a global disease affecting all joint tissues, cartilage degradation is the end point. The degradation of cartilage results of the combination of mechanical stress and biochemical factors, mainly metalloproteinases and reactive oxygen species (ROS). The activity of reactive oxygen species is balanced by enzymatic and non-enzymatic antioxidants, that act by inhibiting oxidative enzymes, scavenging free radicals or chelating ion metals. Until now, few information is available on the antioxidative status of chondrocytes. Further, the modification of the antioxidative system in osteoarthritis remains unknown. Some antioxidant supplements or drugs with antioxidant properties have been developed to reinforce the cellular antioxidant status. However, until now, there is no consistent evidence that additional antioxidant supply is efficient to relieve OA symptoms or to prevent structural changes in OA cartilage.
引用
收藏
页码:347 / 357
页数:11
相关论文
共 200 条
[1]
INHIBITION OF HYDROXYL-RADICAL-GENERATED DNA-DEGRADATION BY METALLOTHIONEIN [J].
ABEL, J ;
DERUITER, N .
TOXICOLOGY LETTERS, 1989, 47 (02) :191-196
[2]
Hype about glucosamine [J].
Adams, ME .
LANCET, 1999, 354 (9176) :353-354
[3]
Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1β-induced expression of matrix metalloproteinase-1 and-13 in human chondrocytes [J].
Ahmed, S ;
Wang, NZ ;
Lalonde, M ;
Goldberg, VM ;
Haqqi, TM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02) :767-773
[4]
INTEGRINS AND OTHER CELL-ADHESION MOLECULES [J].
ALBELDA, SM ;
BUCK, CA .
FASEB JOURNAL, 1990, 4 (11) :2868-2880
[5]
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis [J].
Altman, RD ;
Abadie, E ;
Avouac, B ;
Bouvenot, G ;
Branco, J ;
Bruyere, O ;
Calvo, G ;
Devogelaer, JP ;
Dreiser, RL ;
Herrero-Beaumont, G ;
Kahan, A ;
Kreutz, G ;
Laslop, A ;
Lemmel, EM ;
Menkes, CJ ;
Pavelka, K ;
Van De Putte, L ;
Vanhaelst, L ;
Reginster, JY .
OSTEOARTHRITIS AND CARTILAGE, 2005, 13 (01) :13-19
[6]
ANDERSON D, 1990, PROG CLIN BIOL RES, V340, P361
[7]
Appelboom T, 2001, SCAND J RHEUMATOL, V30, P242
[8]
Corticosteroid injections for osteoarthritis of the knee: meta-analysis [J].
Arroll, B ;
Goodyear-Smith, F .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7444) :869-870A
[9]
Balazs EA, 1993, J RHEUMATOL S, V39
[10]
Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro [J].
Bassleer, C ;
Rovati, L ;
Franchimont, P .
OSTEOARTHRITIS AND CARTILAGE, 1998, 6 (06) :427-434